Financial Instruments (Tables)
|
12 Months Ended |
Dec. 31, 2019 |
| Fair Value Disclosures [Abstract] |
|
| Available-for-sale debt securities |
The following tables summarize our debt securities by significant investment categories as of December 31, 2018 and 2019 (in millions): | | | | | | | | | | | | | | | | | | | | | | | | | | As of December 31, 2018 | | Adjusted Cost | | Gross Unrealized Gains | | Gross Unrealized Losses | | Fair Value | | Cash and Cash Equivalents | | Marketable Securities | Level 2: | | | | | | | | | | | | Time deposits(1) | $ | 2,202 |
| | $ | 0 |
| | $ | 0 |
| | $ | 2,202 |
| | $ | 2,202 |
| | $ | 0 |
| Government bonds | 53,634 |
| | 71 |
| | (414 | ) | | 53,291 |
| | 3,717 |
| | 49,574 |
| Corporate debt securities | 25,383 |
| | 15 |
| | (316 | ) | | 25,082 |
| | 44 |
| | 25,038 |
| Mortgage-backed and asset-backed securities | 16,918 |
| | 11 |
| | (324 | ) | | 16,605 |
| | 0 |
| | 16,605 |
| Total | $ | 98,137 |
| | $ | 97 |
| | $ | (1,054 | ) | | $ | 97,180 |
| | $ | 5,963 |
| | $ | 91,217 |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | As of December 31, 2019 | | Adjusted Cost | | Gross Unrealized Gains | | Gross Unrealized Losses | | Fair Value | | Cash and Cash Equivalents | | Marketable Securities | Level 2: | | | | | | | | | | | | Time deposits(1) | $ | 2,294 |
| | $ | 0 |
| | $ | 0 |
| | $ | 2,294 |
| | $ | 2,294 |
| | $ | 0 |
| Government bonds | 55,033 |
| | 434 |
| | (30 | ) | | 55,437 |
| | 4,518 |
| | 50,919 |
| Corporate debt securities | 27,164 |
| | 337 |
| | (3 | ) | | 27,498 |
| | 44 |
| | 27,454 |
| Mortgage-backed and asset-backed securities | 19,453 |
| | 96 |
| | (41 | ) | | 19,508 |
| | 0 |
| | 19,508 |
| Total | $ | 103,944 |
| | $ | 867 |
| | $ | (74 | ) | | $ | 104,737 |
| | $ | 6,856 |
| | $ | 97,881 |
|
(1) The majority of our time deposits are domestic deposits.
|
| Investments by maturity date |
The following table summarizes the estimated fair value of our investments in marketable debt securities with stated contractual maturity dates, accounted for as available-for-sale securities and classified by the contractual maturity date of the securities (in millions): | | | | | | As of December 31, 2019 | Due in 1 year | $ | 20,392 |
| Due in 1 year through 5 years | 63,151 |
| Due in 5 years through 10 years | 2,671 |
| Due after 10 years | 11,667 |
| Total | $ | 97,881 |
|
|
| Schedule of unrealized loss on debt securities |
The following tables present gross unrealized losses and fair values for those investments that were in an unrealized loss position as of December 31, 2018 and 2019, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in millions): | | | | | | | | | | | | | | | | | | | | | | | | | | As of December 31, 2018 | | Less than 12 Months | | 12 Months or Greater | | Total | | Fair Value | | Unrealized Loss | | Fair Value | | Unrealized Loss | | Fair Value | | Unrealized Loss | Government bonds | $ | 12,019 |
| | $ | (85 | ) | | $ | 23,877 |
| | $ | (329 | ) | | $ | 35,896 |
| | $ | (414 | ) | Corporate debt securities | 10,171 |
| | (107 | ) | | 11,545 |
| | (209 | ) | | 21,716 |
| | (316 | ) | Mortgage-backed and asset-backed securities | 5,534 |
| | (75 | ) | | 8,519 |
| | (249 | ) | | 14,053 |
| | (324 | ) | Total | $ | 27,724 |
| | $ | (267 | ) | | $ | 43,941 |
| | $ | (787 | ) | | $ | 71,665 |
| | $ | (1,054 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | | | As of December 31, 2019 | | Less than 12 Months | | 12 Months or Greater | | Total | | Fair Value | | Unrealized Loss | | Fair Value | | Unrealized Loss | | Fair Value | | Unrealized Loss | Government bonds | $ | 6,752 |
| | $ | (20 | ) | | $ | 4,590 |
| | $ | (10 | ) | | $ | 11,342 |
| | $ | (30 | ) | Corporate debt securities | 1,665 |
| | (2 | ) | | 978 |
| | (1 | ) | | 2,643 |
| | (3 | ) | Mortgage-backed and asset-backed securities | 4,536 |
| | (13 | ) | | 2,835 |
| | (28 | ) | | 7,371 |
| | (41 | ) | Total | $ | 12,953 |
| | $ | (35 | ) | | $ | 8,403 |
| | $ | (39 | ) | | $ | 21,356 |
| | $ | (74 | ) |
|
| Gains and losses on equity securities |
Gains and losses reflected in other income (expense), net, for our marketable and non-marketable equity securities are summarized below (in millions): | | | | | | | | | | Year Ended December 31, | | 2018 | | 2019 | Net gain (loss) on equity securities sold during the period | $ | 1,458 |
| | $ | (301 | ) | Net unrealized gain (loss) on equity securities held as of the end of the period(1) | 4,002 |
| | 2,950 |
| Total gain (loss) recognized in other income (expense), net | $ | 5,460 |
| | $ | 2,649 |
|
(1) Includes net gains of $4.1 billion and $1.8 billion related to non-marketable equity securities for the years ended December 31, 2018 and 2019, respectively.
|
| Cumulative net gains on equity securities sold |
| | | | | | | | | | Equity Securities Sold During the Year Ended December 31, | | 2018 | | 2019 | Total sale price | $ | 1,965 |
| | $ | 3,134 |
| Total initial cost | 515 |
| | 858 |
| Cumulative net gains | $ | 1,450 |
| | $ | 2,276 |
|
|
| Summary of unrealized gains and losses for non-marketable equity securities |
The carrying values for our marketable and non-marketable equity securities are summarized below (in millions): | | | | | | | | | | | | | | As of December 31, 2018 | | Marketable Securities | | Non-Marketable Securities | | Total | Total initial cost | $ | 1,168 |
| | $ | 8,168 |
| | $ | 9,336 |
| Cumulative net gain(1) | 54 |
| | 4,107 |
| | 4,161 |
| Carrying value | $ | 1,222 |
| | $ | 12,275 |
| | $ | 13,497 |
|
| | (1) | Non-marketable securities cumulative net gain is comprised of $4.3 billion unrealized gains and $178 million unrealized losses (including impairment). |
| | | | | | | | | | | | | | As of December 31, 2019 | | Marketable Securities | | Non-Marketable Securities | | Total | Total initial cost | $ | 1,935 |
| | $ | 8,297 |
| | $ | 10,232 |
| Cumulative net gain(1) | 1,361 |
| | 3,056 |
| | 4,417 |
| Carrying value | $ | 3,296 |
| | $ | 11,353 |
| | $ | 14,649 |
|
(1) Non-marketable securities cumulative net gain is comprised of $3.5 billion unrealized gains and $445 million unrealized losses (including impairment).
|
| Marketable equity securities |
The following table summarizes marketable equity securities measured at fair value by significant investment categories as of December 31, 2018 and 2019 (in millions): | | | | | | | | | | | | | | | | | | | | As of December 31, 2018 | | As of December 31, 2019 | | | Cash and Cash Equivalents | | Marketable Securities | | Cash and Cash Equivalents | | Marketable Securities | Level 1: | | | | | | | | | Money market funds | | $ | 3,493 |
| | $ | 0 |
| | $ | 4,604 |
| | $ | 0 |
| Marketable equity securities(1) | | 0 |
| | 994 |
| | 0 |
| | 3,046 |
| | | 3,493 |
| | 994 |
| | 4,604 |
| | 3,046 |
| Level 2: | | | | | | | | | Mutual funds | | 0 |
| | 228 |
| | 0 |
| | 250 |
| Total | | $ | 3,493 |
| | $ | 1,222 |
| | $ | 4,604 |
| | $ | 3,296 |
|
(1) The balance as of December 31, 2019 includes investments that were reclassified from non-marketable equity securities following the initial public offering of the issuers.
|
| Total unrealized gain (loss) for non-marketable equity securities |
The following is a summary of unrealized gains and losses recorded in other income (expense), net, and included as adjustments to the carrying value of non-marketable equity securities (in millions): | | | | | | | | | | Year Ended December 31, | | 2018 | | 2019 | Unrealized gains | $ | 4,285 |
| | $ | 2,163 |
| Unrealized losses (including impairment) | (178 | ) | | (372 | ) | Total unrealized gain (loss) for non-marketable equity securities | $ | 4,107 |
| | $ | 1,791 |
|
|
| Schedule of derivative instruments |
The fair values of our outstanding derivative instruments were as follows (in millions): | | | | | | | | | | | | | | | | | | | | As of December 31, 2018 | | | Balance Sheet Location | | Fair Value of Derivatives Designated as Hedging Instruments | | Fair Value of Derivatives Not Designated as Hedging Instruments | | Total Fair Value | Derivative Assets: | | | | | | | | | Level 2: | | | | | | | | | Foreign exchange contracts | | Other current and non-current assets | | $ | 459 |
| | $ | 54 |
| | $ | 513 |
| Total | | | | $ | 459 |
| | $ | 54 |
| | $ | 513 |
| Derivative Liabilities: | | | | | | | | | Level 2: | | | | | | | | | Foreign exchange contracts | | Accrued expenses and other liabilities, current and non-current | | $ | 5 |
| | $ | 228 |
| | $ | 233 |
| Total | | | | $ | 5 |
| | $ | 228 |
| | $ | 233 |
|
| | | | | | | | | | | | | | | | | | | | As of December 31, 2019 | | | Balance Sheet Location | | Fair Value of Derivatives Designated as Hedging Instruments | | Fair Value of Derivatives Not Designated as Hedging Instruments | | Total Fair Value | Derivative Assets: | | | | | | | | | Level 2: | | | | | | | | | Foreign exchange contracts | | Other current and non-current assets | | $ | 91 |
| | $ | 253 |
| | $ | 344 |
| Total | | | | $ | 91 |
| | $ | 253 |
| | $ | 344 |
| Derivative Liabilities: | | | | | | | | | Level 2: | | | | | | | | | Foreign exchange contracts | | Accrued expenses and other liabilities, current and non-current | | $ | 173 |
| | $ | 196 |
| | $ | 369 |
| Total | | | | $ | 173 |
| | $ | 196 |
| | $ | 369 |
|
|
| Schedule of gain (loss) on derivative instruments |
The gains (losses) on derivatives in cash flow hedging and net investment hedging relationships recognized in other comprehensive income (OCI) are summarized below (in millions): | | | | | | | | | | | | | | | | Gains (Losses) Recognized in OCI on Derivatives Before Tax Effect | | | Year Ended December 31, | | | 2017 | | 2018 | | 2019 | Derivatives in Cash Flow Hedging Relationship: | | | | | | | Foreign exchange contracts | | | | | | | Amount included in the assessment of effectiveness | | $ | (955 | ) | | $ | 332 |
| | $ | 38 |
| Amount excluded from the assessment of effectiveness | | 0 |
| | 26 |
| | (14 | ) | Derivatives in Net Investment Hedging Relationship: | | | | | | | Foreign exchange contracts | | | | | | | Amount included in the assessment of effectiveness | | 0 |
| | 136 |
| | 131 |
| Total | | $ | (955 | ) | | $ | 494 |
| | $ | 155 |
|
The effect of derivative instruments on income is summarized below (in millions): | | | | | | | | | | | | | | | | | | | | | | | | | | Gains (Losses) Recognized in Income | | Year Ended December 31, | | 2017 | | 2018 | | 2019 | | Revenues | | Other income (expense), net | | Revenues | | Other income (expense), net | | Revenues | | Other income (expense), net | Total amounts presented in the Consolidated Statements of Income in which the effects of cash flow and fair value hedges are recorded | $ | 110,855 |
| | $ | 1,015 |
| | $ | 136,819 |
| | $ | 7,389 |
| | $ | 161,857 |
| | $ | 5,394 |
| | | | | | | | | | | | | Gains (Losses) on Derivatives in Cash Flow Hedging Relationship: | | | | | | | | | | | | Foreign exchange contracts | | | | | | | | | | | | Amount of gains (losses) reclassified from AOCI to income | $ | (169 | ) | | $ | 0 |
| | $ | (139 | ) | | $ | 0 |
| | $ | 367 |
| | $ | 0 |
| Amount excluded from the assessment of effectiveness recognized in earnings based on an amortization approach | 0 |
| | 0 |
| | 1 |
| | 0 |
| | 88 |
| | 0 |
| Amount excluded from the assessment of effectiveness | 0 |
| | 83 |
| | 0 |
| | 0 |
| | 0 |
| | 0 |
| Gains (Losses) on Derivatives in Fair Value Hedging Relationship: | | | | | | | | | | | | Foreign exchange contracts | | | | | | | | | | | | Hedged items | 0 |
| | 197 |
| | 0 |
| | (96 | ) | | 0 |
| | (19 | ) | Derivatives designated as hedging instruments | 0 |
| | (197 | ) | | 0 |
| | 96 |
| | 0 |
| | 19 |
| Amount excluded from the assessment of effectiveness | 0 |
| | 23 |
| | 0 |
| | 37 |
| | 0 |
| | 25 |
| Gains (Losses) on Derivatives in Net Investment Hedging Relationship: | | | | | | | | | | | | Foreign exchange contracts | | | | | | | | | | | | Amount excluded from the assessment of effectiveness | 0 |
| | 0 |
| | 0 |
| | 78 |
| | 0 |
| | 243 |
| Gains (Losses) on Derivatives Not Designated as Hedging Instruments: | | | | | | | | | | | | Foreign exchange contracts | | | | | | | | | | | | Derivatives not designated as hedging instruments | 0 |
| | (230 | ) | | 0 |
| | 54 |
| | 0 |
| | (413 | ) | Total gains (losses) | $ | (169 | ) | | $ | (124 | ) | | $ | (138 | ) | | $ | 169 |
| | $ | 455 |
| | $ | (145 | ) |
|
| Offsetting assets |
As of December 31, 2018 and 2019, information related to these offsetting arrangements were as follows (in millions): Offsetting of Assets | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | As of December 31, 2018 | | | | | | | | Gross Amounts Not Offset in the Consolidated Balance Sheets, but Have Legal Rights to Offset | | | | Gross Amounts of Recognized Assets | | Gross Amounts Offset in the Consolidated Balance Sheets | | Net Presented in the Consolidated Balance Sheets | | Financial Instruments | | Cash Collateral Received | | Non-Cash Collateral Received | | Net Assets Exposed | Derivatives | $ | 569 |
| | $ | (56 | ) | | $ | 513 |
| | $ | (90 | ) | (1) | $ | (307 | ) | | $ | (14 | ) | | $ | 102 |
| | | | | | | | | | | | | | | | As of December 31, 2019 | | | | | | | | Gross Amounts Not Offset in the Consolidated Balance Sheets, but Have Legal Rights to Offset | | | | Gross Amounts of Recognized Assets | | Gross Amounts Offset in the Consolidated Balance Sheets | | Net Presented in the Consolidated Balance Sheets | | Financial Instruments | | Cash Collateral Received | | Non-Cash Collateral Received | | Net Assets Exposed | Derivatives | $ | 365 |
| | $ | (21 | ) | | $ | 344 |
| | $ | (88 | ) | (1) | $ | (234 | ) | | $ | 0 |
| | $ | 22 |
|
(1) The balances as of December 31, 2018 and 2019 were related to derivative liabilities which are allowed to be net settled against derivative assets in accordance with our master netting agreements.
|
| Offsetting liabilities |
Offsetting of Liabilities | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | As of December 31, 2018 | | | | | | | | Gross Amounts Not Offset in the Consolidated Balance Sheets, but Have Legal Rights to Offset | | | | Gross Amounts of Recognized Liabilities | | Gross Amounts Offset in the Consolidated Balance Sheets | | Net Presented in the Consolidated Balance Sheets | | Financial Instruments | | Cash Collateral Pledged | | Non-Cash Collateral Pledged | | Net Liabilities | Derivatives | $ | 289 |
| | $ | (56 | ) | | $ | 233 |
| | $ | (90 | ) | (2) | $ | 0 |
| | $ | 0 |
| | $ | 143 |
| | | | | | | | | | | | | | | | As of December 31, 2019 | | | | | | | | Gross Amounts Not Offset in the Consolidated Balance Sheets, but Have Legal Rights to Offset | | | Gross Amounts of Recognized Liabilities | | Gross Amounts Offset in the Consolidated Balance Sheets | | Net Presented in the Consolidated Balance Sheets | | Financial Instruments | | Cash Collateral Pledged | | Non-Cash Collateral Pledged | | Net Liabilities | Derivatives | $ | 390 |
| | $ | (21 | ) | | $ | 369 |
| | $ | (88 | ) | (2) | $ | 0 |
| | $ | 0 |
| | $ | 281 |
|
(2) The balances as of December 31, 2018 and 2019 were related to derivative assets which are allowed to be net settled against derivative liabilities in accordance with our master netting agreements.
|